EUVIMED · CrossrefZeitschrift
Hepatic Oncology
ISSN 2045-0923 · Informa UK Limited
Neueste Artikel
Racial and ethnic survival disparities in primary liver cancer in the United States: a National Cancer Database propensity score-matched study
Patient characteristics to guide personalized treatment decisions and prognostication in hepatocellular carcinoma
Treatment patterns and outcomes in US patients with unresectable HCC treated with embolization
Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy
HES V2.0 surpasses GALAD for HCC detection: a review of multi-dimensional biomarker scores and studies
Two-way increased-risk associations between hepatobiliary cancers and other malignancies: a population-based study
Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape
Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma
Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review
JAK/STAT signaling in hepatocellular carcinoma
Selective internal radiation therapy: an effective treatment for hormonal syndromes in pancreatic neuroendocrine tumors
Molecular heterogeneity in hepatocellular carcinoma
Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma
Mechanisms of doxorubicin resistance in hepatocellular carcinoma
Molecular classification of hepatocellular carcinoma: potential therapeutic implications
Implementation of Systems Theory in Liver Cancer Research
APT imaging of hepatocellular carcinoma signals an effective therapeutic response in advance of tumor shrinkage
Role of immunotherapy in the overall survival of gastrointestinal cancer patients with liver metastases
Comparison of long-term clinical outcomes between radiofrequency ablation and hepatic resection in patients with small (≤2 cm) hepatocellular carcinoma
Hepatic arterial infusion chemotherapy in patients with unresectble hepatocellular carcinoma: 3-year survival update
Real-world treatment patterns and outcomes in patients with early-stage HCC in the US treated with resection or ablation
Management of hepatocellular carcinoma prior to liver transplantation: latest developments
Qualitative research to understand the patient experience with advanced and/or metastatic hepatocellular carcinoma
Clinical management of liver cancer patients with immune checkpoint inhibitors treatment
Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?
The role of miRNAs in cholangiocarcinoma
Controversies of preoperative portal vein embolization
Functional imaging of hepatocellular carcinoma
Identifying patients at risk from nonalcoholic fatty liver-related hepatocellular carcinomas
What are the options for hepatocellular carcinoma patients who progress under sorafenib?
EUVIMED